A detailed history of Hantz Financial Services, Inc. transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 447 shares of IART stock, worth $5,252. This represents 0.0% of its overall portfolio holdings.

Number of Shares
447
Previous 157 184.71%
Holding current value
$5,252
Previous $2,000 200.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 04, 2025

BUY
$11.13 - $15.99 $3,227 - $4,637
290 Added 184.71%
447 $6,000
Q2 2025

Aug 04, 2025

BUY
$11.6 - $21.78 $1,821 - $3,419
157 New
157 $2,000
Q3 2022

Aug 06, 2024

BUY
$42.28 - $57.17 $125,952 - $170,309
2,979 Added 112.54%
5,626 $238,000
Q2 2022

Aug 06, 2024

BUY
$53.86 - $66.52 $142,567 - $176,078
2,647 New
2,647 $143,000

Others Institutions Holding IART

About INTEGRA LIFESCIENCES HOLDINGS CORP


  • Ticker IART
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,518,200
  • Market Cap $981M
  • Description
  • Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...
More about IART
Track This Portfolio

Track Hantz Financial Services, Inc. Portfolio

Follow Hantz Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hantz Financial Services, Inc. with notifications on news.